Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002595)

(Analysis AN004267)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11
IMP	ME622497	0.35	0.16	1.98	4.49	0.34	0.81	0.59	1.12	0.18	0.21	0.18
S-AMP	ME622507	0.31	0.21	1.88	3.17	0.29	0.62	0.90	2.01	0.23	0.39	0.46
CMP	ME622485	0.37	1.52	1.98	1.94	0.55	0.43	0.74	0.41	0.41	0.89	0.74
PRPP	ME622505	0.72	0.47	2.60	1.54	0.58	0.34	0.97	0.92	0.82	0.48	0.60
AICAR	ME622481	0.51	1.20	1.99	0.32	1.26	2.03	1.03	0.29	0.47	0.35	0.27
hypoxanthine	ME622496	0.08	0.53	3.62	0.90	0.49	1.13	0.40	0.10	0.60	0.17	0.21
XMP	ME622512	1.07	1.07	2.96	0.38	1.04	0.96	0.62	0.36	0.40	0.52	0.22
NADPH	ME622502	1.33	0.64	0.07	1.61	1.31	2.47	1.45	0.95	0.79	0.36	0.40
AMP	ME622482	0.67	0.78	1.48	0.56	0.65	1.96	0.48	1.50	0.53	1.45	0.66
NaMN	ME622503	1.02	0.80	0.87	0.69	0.54	1.89	0.49	1.72	0.70	0.39	NA
guanine	ME622495	1.31	1.36	1.01	1.20	0.84	0.95	0.28	0.72	0.38	0.98	1.88
ADP	ME622479	1.42	0.99	0.81	1.00	0.83	1.08	0.78	1.12	1.05	1.27	0.76
GDP	ME622490	1.64	1.04	0.21	1.19	0.99	1.03	0.85	1.32	1.15	1.36	0.69
UDP	ME622508	0.88	1.11	0.24	1.15	1.20	1.28	1.13	1.23	0.91	1.30	1.01
CDP	ME622484	0.95	0.89	0.31	1.24	1.09	1.28	1.23	1.23	0.84	1.38	0.99
dTTP	ME622489	0.93	0.89	0.48	1.30	1.01	1.13	1.13	1.31	0.90	1.35	0.89
UDP-galactose	ME622509	0.71	0.94	0.23	0.94	1.19	0.84	1.46	1.18	1.31	1.20	1.47
dATP	ME622487	0.80	0.94	0.67	0.97	1.06	0.91	1.25	1.33	1.17	1.03	1.07
NAD+	ME622499	0.87	1.03	0.49	1.02	1.16	0.91	1.23	1.25	1.17	1.17	1.02
dCTP	ME622488	0.78	1.11	0.37	1.06	1.27	0.84	1.42	1.26	1.10	1.08	1.10
NADP+	ME622501	0.79	1.13	0.22	1.01	1.27	0.93	1.25	1.31	1.21	1.20	1.15
GDP-mannose	ME622491	0.91	1.11	0.17	1.10	1.28	0.88	1.44	1.21	1.13	1.16	1.09
ATP	ME622483	0.93	1.07	0.17	1.09	1.23	0.93	1.35	1.33	1.18	1.21	1.01
CTP	ME622486	0.93	1.09	0.16	1.10	1.24	0.93	1.35	1.30	1.16	1.20	1.05
GTP	ME622493	0.92	1.09	0.14	1.12	1.25	0.93	1.31	1.32	1.19	1.20	1.05
UTP	ME622511	0.95	1.09	0.13	1.09	1.23	0.93	1.31	1.35	1.16	1.21	1.06
5^-methylthioadenosine	ME622498	0.70	1.05	0.72	1.15	1.15	1.11	1.11	1.12	1.39	0.81	0.86
adenine	ME622478	1.05	1.08	0.92	0.97	0.97	1.00	1.06	0.99	1.01	0.99	1.01
NADH	ME622500	1.18	1.03	0.75	1.27	0.93	1.14	1.27	1.07	0.68	0.75	1.08
ZMP	ME622513	0.55	1.37	2.07	0.47	1.15	0.97	0.45	0.79	0.32	1.24	0.66
UMP	ME622510	0.82	1.36	1.73	1.39	0.50	0.76	0.67	0.82	0.62	0.69	1.13
GMP	ME622492	0.81	1.12	1.14	1.41	0.72	1.46	0.82	0.96	0.65	0.91	0.91
NMN	ME622504	0.85	1.17	1.52	0.82	0.87	0.66	1.16	0.95	0.65	1.15	0.90
guanosine	ME622494	0.80	0.85	1.31	0.81	0.78	1.06	1.07	0.92	0.91	1.16	1.15
ADP-ribose	ME622480	0.79	0.86	1.50	1.31	0.87	0.86	0.86	1.08	0.79	0.99	0.80
S-adenosylhomocysteine	ME622506	0.84	0.75	1.50	0.97	0.87	0.94	0.93	1.07	0.79	1.12	0.92

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-ExternalStandard \| Timepoint:0 hour \| Sex:-
F4	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F5	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F6	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F7	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F8	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F9	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F10	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F11	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix